Phase 2b trial of neflamapimod in dementia with Lewy bodies fails to replicate earlier promise
A phase 2b randomized trial found no benefit of neflamapimod on the primary CDR-SB outcome in dementia with Lewy bodies, ...
A phase 2b randomized trial found no benefit of neflamapimod on the primary CDR-SB outcome in dementia with Lewy bodies, ...
A narrative review consolidates neonatal-specific evidence on sildenafil dosing, monitoring and safety across the main forms of newborn pulmonary hypertension.
A machine learning pipeline trained on 192 FDA-approved compounds predicts human oral bioavailability with an R2 of 0.766, outperforming previous ...
A validated HPLC method has captured the first simultaneous pharmacokinetic profiles of betulinic and ursolic acids absorbed from grey mangrove ...
A study of 3,243 Japanese patients found that observed fixed-dose nivolumab billing was a median of 89,540 yen higher per ...
A human erythropoietin fused to an engineered albumin variant showed a 5.2-fold longer plasma half-life and successful intranasal delivery in ...
A randomized crossover study in 35 healthy volunteers found that a 250 mg test capsule and a 300 mg reference ...
A first-in-human phase Ia trial reports that the covalent TEAD palmitoylation inhibitor BPI-460372 showed preliminary antitumor activity in advanced solid ...
A 14-day pharmacokinetic study in ten Japanese postmenopausal women found that a standardized-area transdermal estradiol gel produced dose-proportional serum estradiol ...
A study of 36 Han Chinese women with epilepsy found that levetiracetam and lamotrigine clearance rose sharply during pregnancy, driving ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine